I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cabozantinib plus atezolizumab in previously untreated adva..:
Daneng Li
;
Yohann Loriot
;
Adam M. Burgoyne
...
http://www.sciencedirect.com/science/article/pii/S2589537023005539. , 2024
Link:
https://doi.org/10.1016/j.eclinm.2023.102376
RT Journal T1
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)Research in context
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:4755d3d913804c63b46661b4dce5ecba&Exemplar=1&LAN=DE A1 Daneng Li A1 Yohann Loriot A1 Adam M. Burgoyne A1 James M. Cleary A1 Armando Santoro A1 Daniel Lin A1 Santiago Ponce Aix A1 Ignacio Garrido-Laguna A1 Ramu Sudhagoni A1 Xiang Guo A1 Svetlana Andrianova A1 Scott Paulson PB Elsevier YR 2024 K1 Hepatocellular carcinoma K1 Gastric cancer K1 Gastroesophageal junction adenocarcinoma K1 Cabozantinib K1 Atezolizumab K1 Medicine (General) K1 R5-920 JF http://www.sciencedirect.com/science/article/pii/S2589537023005539 LK http://dx.doi.org/https://doi.org/10.1016/j.eclinm.2023.102376 DO https://doi.org/10.1016/j.eclinm.2023.102376 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)